Pharma and Healthcare - Proteomics Market

Market Snapshot

CAGR:14.50

2020

2028

Source: Reports and data

Study Period	2018-2028
Base Year	2019
CAGR	14.50

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Download Sample Pdf

Market Summary

The global proteomics market size is expected to reach a market size of USD 65.91 billion in 2028 and register a CAGR of 14.5% over the forecast period. Surge in prevalence of genetic diseases, availability of high funding for research, and advancements in technology are primary factors driving growth of the global proteomic market. Proteomics uses advanced technologies for the identification and qualification of proteins, and for the detection of diagnostic markers.

 

Another key factor driving growth of the market is the rising trend of personalized medicine. Biotechnology and pharmaceutical companies have over the years doubled their investment in R&D of personalized medicine. Advancement in proteomics technologies contributed to the development of personalized medicines by enabling detection of proteomics Molecular Diagnostics, protein biomarkers, and pharmacoproteomics, and protein biochips. Personalized medicine is commonly used in cancer treatment.

Proteomics instruments are expensive, which limits their adoption in small-scale enterprises and academic institutions. High cost creates challenges for established players to expand in developing economies, thereby affecting overall market growth.

The COVID-19 pandemic has spurred growth of the proteomics market. Biopharmaceutical companies are investing significantly in research for the development of SARS-COV-2 Vaccines. Researchers are identifying drugs for the treatment of the virus by using separation and identification techniques to examine both new and existing drugs, which is driving growth of the proteomics market.

Product Outlook:

On the basis of product, the market is segmented into instruments, reagents, and services. The reagent segment accounted the largest share in 2019. Growing need for protein separation from complex mixtures for effective analysis and increasing research activities are other key factors expected to support revenue growth of this segment.

Technology Outlook:

On the basis of technology, the market is segmented into x-ray crystallography, chromatography, microarray instruments, protein fractionation systems, surface plasma resonance (SPR) systems, electrophoresis, and spectroscopy.

Chromatography is an indispensable tool in proteomic research as it provides high-resolution, high-speed, and high-sensitivity separation of macromolecules. Moreover, unique features of chromatography will also enable detection of low-abundance species, which will drive its demand in the coming years.

Application Outlook:

On the basis of application, the market is segmented into clinical diagnosis, drug discovery, and others. The drug discovery segment revenue is expected to register the highest growth rate due to increasing application of proteomics in identification of toxicity and efficacy from biological fluids and target validation and identification. High usage in the identification of new drugs is a major driving growth of this segment.

Regional Outlook:

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share in the global proteomics market in 2019. Increasing research activities in the healthcare industry, high funding from governments, and rising need for improved healthcare infrastructure are key factor expected to continue to drive growth of the market.

Market-O-Nomics

• Microarray offers label-free detection, full imprint of proteins, and produce vast volumes of information from small samples, which is driving its demand among biopharmaceutical companies.
• Asia Pacific proteomics market revenue is forecast to register a comparatively higher growth rate due to surge increasing growth in pharmaceutical industry and in Contract Research Organizations (CRO). Presence of less-stringent regulations in countries in the region will also support growth of the market.
• Europe accounted for a revenue share of 31.4% in the global proteomics market in 2019, which is expected to increase at a rate of 15.0% during the forecast period.

Companies considered and profiled in this market study

Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker Corporation, and GE Healthcare, has been profiled in the report.

Players operating in the market are focusing on various strategies, advanced technologies in the field, and development, testing, and introduction of new and more efficient solutions. Some key highlights include:

• In June 2020, Olink Proteomics announced the launch of Olink Explore 1536. The technology is a combination of Next-Generation Sequencing (NGS) technology with the company\'s unique proximity extension assay high-multiplex immunoassay technology.

Start-up Traction

The industry offers numerous growth opportunities. Major and established players are improving existing technologies and solutions and also developing and offering more advanced solutions for a range of growing applications across the healthcare sector and industry. New entrants and startups are also focusing on similar strategies as a means of early market entry.

Deals Landscape

Mergers and acquisitions and strategic agreements are an integral part of the proteomics industry and market.

• In January 2021, Bruker and Seer signed a non-exclusive commercial agreement with Bruker Corporation, which is one of the world’s leading analytical instrumentation companies. Through this agreement, Seer will market the timsTOF Pro mass Spectrometer system together with its Proteograph Product Suite. Joint adoption of Bruker’s high performance timsTOF Pro mass spectrometer with Seer’s Proteograph Product Suite will simplify customer adoption of the market.

Expert Insights:

Reports and data predict emergence of encouraging technological advancements to accelerate the use of proteomics technologies and instruments. According to industry analysts, new companies enter the market, which may theoretically change the situation. New entrants that enter the market must concentrate on innovating and integrating through new technologies while reducing complexity and lowering total operational costs. Experts also believe that increasing the implementation of emerging technology in developed nations would be a critical growth field for the industry. Company strategy review shows that most businesses concentrate on product launch, as well as negotiations to increase their share and scale. Both approaches contributed to the advancement of the technologies and product diversification in the untapped regions. The businesses implemented these approaches to diversify their business within the industries.

Segments Covered in the report

This report forecasts revenue growth at a global, regional, & country level and provides an analysis result of market trends for segments and sub-segments, etc. The scope of the report can be defined as:

For the purpose of this report, Reports and Data has segmented the global proteomics market on the basis of product, technology, application, and region: